Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

Autor: Spencer CN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., McCulloch JA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Vetizou M; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wong MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Badger JH; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Medicine, Monash University, Melbourne, VIC 3004, Australia., Rodrigues RR; Frederick National Laboratory for Cancer Research, and Microbiome and Genetics Core, Laboratory of Integrative Cancer Immunology, CCR, NCI, NIH, Bethesda, MD 20852, USA., Morgun A; Department of Pharmaceutical Science, Oregon State University, Corvallis, OR 97331, USA., Kim YS; Nutritional Science Research Group, Division of Cancer Prevention, NCI, NIH, Rockville, MD 20850, USA., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hoffman KL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Zheng J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA., Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gaudreau PO; Canadian Cancer Trials Group and Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada., Harris AL; Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jamal MA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Baruch EN; Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA., Perez-Guijarro E; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA., Day CP; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA., Merlino G; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA., Pazdrak B; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lochmann BS; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Szczepaniak-Sloane RA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Anderson J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zobniw CM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Posada E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sirmans E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Simon J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Clise-Dwyer K; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schneider S; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Anang NAS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Toker J; Department of Neurosurgery, Harvard University, Cambridge, MA 02138, USA.; Department of Oncology, University of Cambridge, Cambridge CB2 1TN, UK., Malke JC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Woodman SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jensen V; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel., Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nezi L; Dipartimento di Oncologia Sperimentale, Instituto Europeo di Oncologia, Milan, P.I. 08691440153, Italy., Petrosino JF; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lazar AJ; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hu J; Department of Biostatistics, Columbia University, New York, NY 10032, USA., Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Stem Cell Transplant, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tetzlaff MT; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, CA 94115, USA., Yan Y; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA., Garrett WS; Department of Molecular Metabolism, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA., Huttenhower C; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cohen L; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Daniel CR; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2021 Dec 24; Vol. 374 (6575), pp. 1632-1640. Date of Electronic Publication: 2021 Dec 23.

Interaction of molecular alterations with immune response in melanoma.

Autor: Szczepaniak Sloane RA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Reddy SM; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang X; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Reuben A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer [Cancer] 2017 Jun 01; Vol. 123 (S11), pp. 2130-2142.

TIGIT⁺ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients.

Autor: Tsakmaklis, Anastasia^1,2 (AUTHOR), Farowski, Fedja^1,2,3 (AUTHOR), Zenner, Rafael¹ (AUTHOR), Lesker, Till Robin⁴ (AUTHOR), Strowig, Till^4,5,6 (AUTHOR), Schlößer, Hans^7,8 (AUTHOR), Lehmann, Jonas^7,8 (AUTHOR), von Bergwelt-Baildon, Michael¹ (AUTHOR), Mauch, Cornelia⁹ (AUTHOR), Schlaak, Max¹⁰ (AUTHOR), Knuever, Jana⁹ (AUTHOR), Schweinsberg, Viola⁹ (AUTHOR), Heinzerling, Lucie M.^11,12 (AUTHOR), Vehreschild, Maria J. G. T.^1,2,3,13 (AUTHOR) vehreschild@med.uni-frankfurt.de

Publikováno v: BMC Cancer. 11/28/2023, Vol. 23 Issue 1, p1-11. 11p.

Gender Differences in Authorship and Quality of Anesthesia Clinical Practice Guidelines From 2016 to 2020 Using the Appraisal of Guidelines for Research and Evaluation II Instrument.

Autor: Rong, Lisa Q., Martinez, Andrew P., Rahouma, Mohamed, Lopes, Alexandra J., Lee, Jerry Y., Wright, Drew N., Demetres, Michelle, Kachulis, Bessie, O'Shaughnessy, Sinead M.

Publikováno v: Anesthesia & Analgesia; Nov2024, Vol. 139 Issue 5, p955-964, 10p

On achieving gender equity within the liver transplantation medical and surgical workforce.

Autor: Verran, Deborah

Publikováno v: Frontiers in Transplantation; 2024, p1-5, 5p